CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,738,780 | -31.3% | 234,284 | -21.0% | 0.32% | -27.9% |
| Q2 2023 | $3,984,906 | -21.0% | 296,496 | -2.5% | 0.44% | -27.8% |
| Q1 2023 | $5,043,487 | -10.9% | 304,191 | -0.0% | 0.62% | -14.1% |
| Q4 2022 | $5,658,771 | +44.9% | 304,235 | -0.0% | 0.72% | +6.9% |
| Q3 2022 | $3,904,000 | +82.9% | 304,293 | -0.1% | 0.67% | +28.8% |
| Q2 2022 | $2,135,000 | -15.4% | 304,515 | 0.0% | 0.52% | +1.8% |
| Q1 2022 | $2,524,000 | -38.8% | 304,515 | -50.0% | 0.51% | +21.3% |
| Q4 2021 | $4,124,000 | +155.5% | 609,030 | +100.0% | 0.42% | +19.9% |
| Q3 2021 | $1,614,000 | -54.1% | 304,515 | -50.2% | 0.35% | -44.2% |
| Q2 2021 | $3,514,000 | +24.9% | 611,107 | +0.1% | 0.63% | +23.0% |
| Q1 2021 | $2,814,000 | +123.9% | 610,491 | +62.3% | 0.51% | +91.4% |
| Q4 2020 | $1,257,000 | – | 376,207 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |